These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 12418122)

  • 21. Coarctation Long-term Assessment (COALA): significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material.
    Hager A; Kanz S; Kaemmerer H; Schreiber C; Hess J
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):738-45. PubMed ID: 17723827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypotensive effect of 6-months cardiac rehabilitation in elderly patients].
    Kałka D; Sobieszczańska M; Marciniak W; Chorebała A; Markuszewski L; Metner E; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):95-100. PubMed ID: 17598651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension.
    Eto M; Toba K; Akishita M; Kozaki K; Watanabe T; Kim S; Hashimoto M; Ako J; Iijima K; Sudoh N; Yoshizumi M; Ouchi Y
    Hypertens Res; 2005 Jan; 28(1):1-7. PubMed ID: 15969248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association between activity or fitness and loss of control of hypertension.
    Casson RI; King WD; Godwin NM; Petrella RJ;
    Can J Cardiol; 2003 Dec; 19(13):1485-9. PubMed ID: 14760437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent nurse visits decrease white coat effect in stage III hypertension.
    Guerra-Riccio GM; Artigas Giorgi DM; Consolin-Colombo FM; Barreto-Filho JA; Lopes HF; Fleury Camargo AL; Moacyr Krieger E
    Am J Hypertens; 2004 Jun; 17(6):523-8. PubMed ID: 15177526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of rofecoxib on 24-h ambulatory blood pressure and heart rate monitoring in patients with hypertension and osteoarthritis.
    Derici U; Goker B; Ayerden-Ebinc F; Altok KR; Erten Y; Haznedaroglu S; Aydin M; Arinsoy T; Sindel S
    Int J Tissue React; 2005; 27(2):69-73. PubMed ID: 16035651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The nitric oxide system in patients with arterial hypertension living in high mountains].
    Kurdanova MKh; Beslaneev IA; Batyrbekova LM; Berkhamova ZA; Sarbasheva AKh; Kurdanov KhA
    Ter Arkh; 2007; 79(12):25-8. PubMed ID: 18220026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy.
    Prescrire Int; 2008 Apr; 17(94):47-50. PubMed ID: 18516803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patients.
    Tayama J; Munakata M; Yoshinaga K; Toyota T
    Hypertens Res; 2006 Jun; 29(6):403-9. PubMed ID: 16940702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
    Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
    ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
    Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
    J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
    Mosso L; Carvajal C; Campino C; Rojas A; González A; Barraza A; Montero J; Fardella C
    Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension.
    Hannila-Handelberg T; Kontula K; Tikkanen I; Tikkanen T; Fyhrquist F; Helin K; Fodstad H; Piippo K; Miettinen HE; Virtamo J; Krusius T; Sarna S; Gautschi I; Schild L; Hiltunen TP
    BMC Med Genet; 2005 Jan; 6():4. PubMed ID: 15661075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
    Paris B; Bobrie G; Rossignol P; Le Coz S; Chedid A; Plouin PF
    J Hypertens; 2006 Aug; 24(8):1649-54. PubMed ID: 16877969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologic tailoring of therapy for resistant hypertension: 20 years' experience with stimulated renin profiling.
    Spence JD
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1077-83. PubMed ID: 10604483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.